To validate these findings in the context of human cancer cells, we knocked down CDC20 in the human colon cancer cell line HCT116, either by siRNA or by shRNA (Fig. EV2A–D), and assessed cell survival and proliferation under SAC inhibition. This evidence concerns the gene CDC20 and colonic neoplasm.